Retrieve available abstracts of 130 articles: HTML format
Single Articles
July 2025
LIU ZQ, Zang SB, OuYang PY, Jing BZ, et al Multimodal prognostic model for de novo metastatic nasopharyngeal carcinoma after
first-line immunochemotherapy.
Radiother Oncol. 2025 Jul 1:111010. doi: 10.1016/j.radonc.2025.111010. PubMedAbstract available
YANG F, Wang D, Su Y, Tang J, et al The dynamic changes of glymphatic function at different post-radiotherapy stages
in patients with nasopharyngeal carcinoma.
Radiother Oncol. 2025 Jul 1:111012. doi: 10.1016/j.radonc.2025.111012. PubMedAbstract available
June 2025
POPULAIRE P, Defraene G, Liu Y, Titt U, et al Dose to the left ventricle is associated to the risk of acute cardiac toxicity in
patients with esophageal cancer undergoing trimodality treatment.
Radiother Oncol. 2025;209:111002. PubMedAbstract available
ZHENG Q, Yu X, Pan W, Ai Y, et al Deep learning dosiomics in grade 4 radiation-induced lymphopenia prediction in
radiotherapy for esophageal cancer: a multi-center study.
Radiother Oncol. 2025;209:110995. PubMedAbstract available
LI Y, Liang J, Fu G, Pan J, et al Non-linear early rapid hippocampal atrophy and associated microstructural injury
in patients with nasopharyngeal carcinoma after radiotherapy: Implications for
hippocampal protection.
Radiother Oncol. 2025;209:110997. PubMedAbstract available
LI J, He HG, Guan C, Ding Y, et al Dynamic joint prediction model of severe radiation-induced oral mucositis among
nasopharyngeal carcinoma: a prospective longitudinal study.
Radiother Oncol. 2025;209:110993. PubMedAbstract available
MOHARRAMI M, Watson E, Huang SH, Madathil S, et al Defining the optimal radiation thresholds for Stratifying jaw osteoradionecrosis
risk in head and neck cancer.
Radiother Oncol. 2025;209:110996. PubMedAbstract available
BACHMANN N, Ahmadsei M, Hurlimann M, Gabrys HS, et al Cone-beam computed tomography-based online adaptive radiotherapy of esophageal
cancer in the neoadjuvant setting: Dosimetric analysis, toxicity and treatment
response.
Radiother Oncol. 2025;209:110981. PubMedAbstract available
NGAN TH, Yeh SH, Tien HJ, Hsu CX, et al Bao Yuan Gao vs. Calendula cream for radiotherapy-induced skin toxicity in head
and neck cancer: A randomized controlled trial.
Radiother Oncol. 2025;209:110976. PubMedAbstract available
NIELSEN AM, Laursen MRT, Rechner LA, Krog SM, et al Esophagus-sparing radiotherapy for complicated spinal metastases (ESO-SPARE). A
randomized phase III clinical trial.
Radiother Oncol. 2025;207:110906. PubMedAbstract available
YARLAGADDA S, Rohe RM, McNeill V, Nemec JR, et al Tubarial gland sparing for oropharyngeal cancer: Feasibility with intensity
modulated proton therapy & intensity modulated radiation therapy.
Radiother Oncol. 2025;207:110882. PubMedAbstract available
GAWRYSZUK A, van der Laan HP, Vergeer MR, Veening M, et al Improved NTCP model for late radiation-induced aspiration based on dose delivered
to specific aspiration-related OARs.
Radiother Oncol. 2025;207:110871. PubMedAbstract available
HUGHES A, Johnny C, Huang SH, Su J, et al The prognostic and predictive value of pre-treatment hematologic markers for
oropharyngeal carcinoma stratified by HPV status and treated with definitive
(chemo) radiation.
Radiother Oncol. 2025;207:110851. PubMedAbstract available
MA B, Guo J, Dijk LVV, Langendijk JA, et al PET and CT based DenseNet outperforms advanced deep learning models for outcome
prediction of oropharyngeal cancer.
Radiother Oncol. 2025;207:110852. PubMedAbstract available
May 2025
XIANG Z, Yu X, Lin S, Wang D, et al Deep learning dosiomics for the pretreatment prediction of radiation dermatitis
in nasopharyngeal carcinoma patients treated with radiotherapy.
Radiother Oncol. 2025 May 22:110951. doi: 10.1016/j.radonc.2025.110951. PubMedAbstract available
YI X, Yu X, Li C, Li J, et al Deep learning Radiopathomics based on pretreatment MRI and whole slide images for
predicting overall survival in locally advanced nasopharyngeal carcinoma.
Radiother Oncol. 2025;209:110949. PubMedAbstract available
DING J, Yin X, Lin Y, Liao X, et al Transforming the management of radiotherapy-induced hypothyroidism in
nasopharyngeal carcinoma through an Innovative individualized radiation dosage
model: A multicenter retrospective analysis.
Radiother Oncol. 2025;208:110943. PubMedAbstract available
CHEN SY, Duan XT, Xie RL, Han YQ, et al Radiation-induced rhinosinusitis in patients with nasopharyngeal carcinoma.
Radiother Oncol. 2025 May 2:110913. doi: 10.1016/j.radonc.2025.110913. PubMedAbstract available
KONG W, Huiskes M, Habraken SJM, Astreinidou E, et al 'iCycle-pBAO': Automated patient-specific beam-angle selection in proton therapy
applied to oropharyngeal cancer.
Radiother Oncol. 2025;206:110799. PubMedAbstract available
CARSUZAA F, Favier V, Seguin L, Turri-Zanoni M, et al Consensus for a postoperative atlas of sinonasal substructures from a modified
Delphi study to guide radiotherapy in sinonasal malignancies.
Radiother Oncol. 2025;206:110784. PubMedAbstract available
April 2025
YAN Y, Zhao F Response to the commentary on "Optimizing fractionation schedules for
de-escalation radiotherapy in head and neck cancers using deep reinforcement
learning" by Mohammad Zahid, and Heiko Enderling.
Radiother Oncol. 2025;208:110903. PubMed
ERIKSEN JG, Maare C, Johansen J, Primdahl H, et al DAHANCA19: A randomized phase III study of primary curative (chemo)-radiotherapy
and the EGFR-inhibitor zalutumumab for squamous cell carcinoma of the head and
neck.
Radiother Oncol. 2025 Apr 19:110899. doi: 10.1016/j.radonc.2025.110899. PubMedAbstract available
CAVALIERI S, Brakenhoff RH, Leemans CR, Hoebers FJP, et al Prognostic gene expression signatures for HPV-negative head and neck squamous
cell carcinoma.
Radiother Oncol. 2025 Apr 17:110900. doi: 10.1016/j.radonc.2025.110900. PubMedAbstract available
WANG Z, Li L, Wu Y, Liu Z, et al Development and validation of Prediction models for radiation-induced hypoglossal
neuropathy in patients with nasopharyngeal carcinoma.
Radiother Oncol. 2025 Apr 8:110887. doi: 10.1016/j.radonc.2025.110887. PubMedAbstract available
HIRAOKA S, Hirashima H, Nakamura M, Tanaka F, et al Integration test of biaxially rotational dynamic-radiation therapy for
nasopharyngeal carcinoma: Efficacy evaluation and dosimetric analysis.
Radiother Oncol. 2025;207:110879. PubMedAbstract available
YANG F, Peng W, Wei H, Li X, et al Pretreatment arterial spin labeling combined with radiological depth of invasion
predicts treatment outcome in nonmetastatic NPC.
Radiother Oncol. 2025;205:110765. PubMedAbstract available
March 2025
ZENG Y, Hu Y, Wang L, Liao Z, et al Control of dental calculus Prevents severe Radiation-Induced oral mucositis in
patients undergoing radiotherapy for nasopharyngeal carcinoma.
Radiother Oncol. 2025 Mar 27:110872. doi: 10.1016/j.radonc.2025.110872. PubMedAbstract available
LI R, Wang X, Luo J, Bai H, et al Determining the optimal radiation dose for locally advanced esophageal cancer: A
pooled analysis of reconstructed individual patient data from randomized clinical
trials.
Radiother Oncol. 2025;207:110867. PubMedAbstract available
YAN Y, Sun X, Chen Y, Sun Z, et al Optimizing fractionation schedules for de-escalation radiotherapy in head and
neck cancers using deep reinforcement learning.
Radiother Oncol. 2025;207:110833. PubMedAbstract available
KRISTENSEN MH, Nielsen SB, Alsner J, Sander Holm AI, et al A systematic review and proportional meta-analysis of image-based pattern of
loco-regional failure analyses outcomes in head and neck squamous cell carcinoma.
Radiother Oncol. 2025 Mar 13:110838. doi: 10.1016/j.radonc.2025.110838. PubMedAbstract available
ZAYED S, Lang P, Read N, Correa RJM, et al Opioid therapy vs. Multimodal analgesia in head and neck cancer (OPTIMAL-HN):
Results of a randomized clinical trial.
Radiother Oncol. 2025 Mar 5:110831. doi: 10.1016/j.radonc.2025.110831. PubMedAbstract available
February 2025
ANTUNES J, Young T, Pittock D, Jacobs P, et al Assessing multiple MRI sequences in deep learning-based synthetic CT generation
for MR-only radiation therapy of head and neck cancers.
Radiother Oncol. 2025 Feb 8:110782. doi: 10.1016/j.radonc.2025.110782. PubMedAbstract available
VAN DER LAAN HP, Gawryszuk A, van der Schaaf A, Langendijk JA, et al Risk reduction of radiation-induced aspiration by sparing specific
aspiration-related-organs at risk; an in silico feasibility study.
Radiother Oncol. 2025;203:110698. PubMedAbstract available
January 2025
WAN D, Liu Q, Wei JS Comment on "Risk factors of level Ib lymph node metastasis and clinical outcome
of its selectively prophylactic irradiation in nasopharyngeal carcinoma: A
real-world study".
Radiother Oncol. 2025;205:110767. PubMed
ZHAO C, Miao J Response to Dr. Dan Wan, Qing Liu, and Jia-Sha Wei's Letter to the Editor of
Radiotherapy and Oncology regarding the paper titled "Comment on "Risk factors of
level Ib lymph node metastasis and clinical outcome of its selectively
prophylactic irradiat
Radiother Oncol. 2025 Jan 30:110768. doi: 10.1016/j.radonc.2025.110768. PubMed
ZHONG J, Chen H, Chen X, Ma N, et al Identifying adverse nodal features associated with poor prognosis in stage IB
nasopharyngeal carcinoma patients based on the 9th AJCC/UICC staging system:
Implications for treatment intensification.
Radiother Oncol. 2025;205:110747. PubMedAbstract available
NEH H, de Vette SPM, Stoffers RH, Zhou G, et al Normal tissue complication probability model predicting taste impairment in head
and neck cancer patients: Evaluating the taste bud bearing tongue mucosa as a
predictor.
Radiother Oncol. 2025 Jan 28:110746. doi: 10.1016/j.radonc.2025.110746. PubMedAbstract available
TORAIH E, Hussein M, Elshazli R, Abdelmaksoud A, et al Therapeutic outcomes and safety of radiofrequency ablation for primary papillary
thyroid carcinoma: A game-changing meta-analysis.
Radiother Oncol. 2025;205:110706. PubMedAbstract available
RAJENDRAN P, Yang Y, Niedermayr TR, Gensheimer M, et al Large language model-augmented learning for auto-delineation of treatment targets
in head-and-neck cancer radiotherapy.
Radiother Oncol. 2025;205:110740. PubMedAbstract available
NERICH V, Falcoz A, Nadin L, Meurisse A, et al Cost-minimization analysis of the GORTEC 2014-04 randomized phase II study of
stereotactic ablative radiotherapy (SABR) or chemotherapy-SABR in oligometastatic
head and neck cancer.
Radiother Oncol. 2025;204:110726. PubMedAbstract available
CHEN L, Li J, Li K, Hu J, et al Corrigendum to "Evaluation and analysis of risk factors of hearing impairment for
nasopharyngeal carcinoma treated using intensity-modulated radiotherapy"
[Radiother. Oncol. 190 (2024) 109985].
Radiother Oncol. 2025;204:110719. PubMed
LU T, Gao X, Yu Z, Liu L, et al Reducing radiation-induced hypothyroidism by modified delineation of cervical
lymphatic drainage area for nasopharyngeal carcinoma treated by
intensity-modulated radiation Therapy: 3 years' experience.
Radiother Oncol. 2025;204:110713. PubMedAbstract available
KAMPEL L, Feldstein S, Tsuriel S, Trejo LL, et al TP53 genetic heterogeneity in recurrent or second primary head and neck squamous
cell carcinoma.
Radiother Oncol. 2025;204:110714. PubMedAbstract available
MENG X, Ju Z, Sakai M, Li Y, et al Normal tissue complication probability model for acute oral mucositis in patients
with head and neck cancer undergoing carbon ion radiation therapy based on
dosimetry, radiomics, and dosiomics.
Radiother Oncol. 2025;204:110709. PubMedAbstract available
ZHANG L, Zhang Z, Wang Y, Zhu Y, et al Evaluation of machine learning models for predicting xerostomia in adults with
head and neck cancer during proton and heavy ion radiotherapy.
Radiother Oncol. 2025;204:110712. PubMedAbstract available
LIU Y, Chen Z, Zhou Q, Shang X, et al A feasibility study of dose-band prediction in radiation therapy: Predicting a
spectrum of plan dose.
Radiother Oncol. 2025;202:110593. PubMedAbstract available
December 2024
WINTER RM, Boeke S, Leibfarth S, Habrich J, et al Clinical validation of a prognostic preclinical magnetic resonance imaging
biomarker for radiotherapy outcome in head-and-neck cancer.
Radiother Oncol. 2024;204:110702. PubMedAbstract available
RUHLE A, Weymann M, Behrens M, Olbrich J, et al Predicting cisplatin tolerability in older adults with head and neck cancer -
Insights for improved chemoradiation outcomes.
Radiother Oncol. 2024 Dec 24:110697. doi: 10.1016/j.radonc.2024.110697. PubMedAbstract available
GIRAUD P, Guihard S, Thureau S, Guilbert P, et al Prediction of the need of enteral nutrition during radiation therapy for head and
neck cancers.
Radiother Oncol. 2024 Dec 21:110693. doi: 10.1016/j.radonc.2024.110693. PubMedAbstract available
HE SQ, Liu GY, Yu YH, Wang L, et al Efficacy of local-regional radiotherapy in de novo metastatic nasopharyngeal
carcinoma patients receiving chemo-immunotherapy: A multicenter, propensity score
matching study.
Radiother Oncol. 2024 Dec 19:110687. doi: 10.1016/j.radonc.2024.110687. PubMedAbstract available
ZHANG S, Yan L, Li R, Zhao Y, et al Development and validation of a nomogram to predict overall survival in patients
with External auditory canal cancer.
Radiother Oncol. 2024 Dec 19:110691. doi: 10.1016/j.radonc.2024.110691. PubMedAbstract available
HUANG X, Lin K, Chen W, Zhang D, et al Modulation of the local angiotensin II: Augmentation of ferroptosis and
radiosensitivity in nasopharyngeal carcinoma via the HIF-1alpha-HILPDA axis.
Radiother Oncol. 2024 Dec 19:110686. doi: 10.1016/j.radonc.2024.110686. PubMedAbstract available
KOCH A, Reinhardt P, Elicin O, Aebersold DM, et al Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis
and dysphagia in head and neck cancer: A systematic review.
Radiother Oncol. 2024 Dec 18:110689. doi: 10.1016/j.radonc.2024.110689. PubMedAbstract available
LIANG JL, Wen YF, Huang YP, Guo J, et al A prognostic and predictive model based on deep learning to identify optimal
candidates for intensity-modulated radiotherapy alone in patients with stage II
nasopharyngeal carcinoma: A retrospective multicenter study.
Radiother Oncol. 2024;203:110660. PubMedAbstract available
LI R, Zhao Y, Wu K, Li H, et al p16 status or response to induction chemotherapy, which predicts survival
outcomes in Chinese oropharyngeal cancer treated with definitive radiotherapy?
Radiother Oncol. 2024;201:110578. PubMedAbstract available
November 2024
MALLICK S Response to "Optimizing palliative radiation: Beyond dose escalation in advanced
head and neck squamous cell carcinoma".
Radiother Oncol. 2024;202:110656. PubMed
SHI X, Hui B, Wang Y, Lu Y, et al Optimizing palliative radiation: Beyond dose escalation in advanced head and neck
squamous cell carcinoma.
Radiother Oncol. 2024 Nov 29:110655. doi: 10.1016/j.radonc.2024.110655. PubMed
JIMENEZ-LABAIG P, Aymerich C, Rullan A, Cacicedo J, et al Prevalence of depressive and anxiety symptoms in patients with head and neck
cancer undergoing radiotherapy: A systematic review and meta-analysis of
longitudinal studies.
Radiother Oncol. 2024;202:110649. PubMedAbstract available
WU CN, Wang JD, Chen WC, Lin CY, et al Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in
patients with nasopharyngeal carcinoma: A long-term, multicenter cohort study.
Radiother Oncol. 2024 Nov 23:110648. doi: 10.1016/j.radonc.2024.110648. PubMedAbstract available
LIU M, Pang B, Chen S, Zeng Y, et al Deep learning-based multiple-CT optimization: An adaptive treatment planning
approach to account for anatomical changes in intensity-modulated proton therapy
for head and neck cancers.
Radiother Oncol. 2024;202:110650. PubMedAbstract available
URSINO S, Malfatti G, Felice F, Bonomo P, et al Deglutition preservation after swallowing (Swoars)-sparing IMRT in head and neck
cancers: Definitive results of A multicenter prospective study of the italian
association of radiotherapy and clinical oncology (Airo).
Radiother Oncol. 2024 Nov 22:110651. doi: 10.1016/j.radonc.2024.110651. PubMedAbstract available
HUANG LW, Pan JW, Li B, Wu WX, et al Evaluation of radiation induced brain injury in nasopharyngeal carcinoma patients
based on multi-parameter quantitative MRI: A prospective longitudinal study.
Radiother Oncol. 2024 Nov 11:110621. doi: 10.1016/j.radonc.2024.110621. PubMedAbstract available
ZHU MY, Wu HJ, Fang T, Zhang GS, et al Risk factors of level Ib lymph node metastasis and clinical outcome of its
selectively prophylactic irradiation in nasopharyngeal carcinoma: A real-world
study.
Radiother Oncol. 2024 Nov 11:110620. doi: 10.1016/j.radonc.2024.110620. PubMedAbstract available
MALLICK S, Dagar A, Ghosh A, Aashita, et al Optimum radiation dose for palliation in head and neck squamous cell carcinoma
(OpRAH) - A phase 3 randomized controlled trial.
Radiother Oncol. 2024 Nov 8:110611. doi: 10.1016/j.radonc.2024.110611. PubMedAbstract available
DE LEEUW ALMP, Giralt J, Tao Y, Benavente S, et al Protocol compliance in a multicentric phase III trial investigating scheduled
adaptive radiotherapy and dose painting in head and neck cancer.
Radiother Oncol. 2024 Nov 8:110612. doi: 10.1016/j.radonc.2024.110612. PubMedAbstract available
VAN BRUGGEN IG, van Dijk M, Brinkman-Akker MJ, Lofman F, et al Clinical implementation of deep learning robust IMPT planning in oropharyngeal
cancer patients: A blinded clinical study.
Radiother Oncol. 2024;200:110522. PubMedAbstract available
YANG WC, Koto M, Ikawa H, Imai R, et al Clinical target volume design and dose in carbon-ion radiation therapy for
sinonasal mucosal melanoma.
Radiother Oncol. 2024;200:110511. PubMedAbstract available
XU MH, Dou JP, Guo MH, Yi WQ, et al Risk factors for recurrent laryngeal nerve injury in microwave ablation of
thyroid nodules: A multicenter study.
Radiother Oncol. 2024;200:110516. PubMedAbstract available
CHEN AM De-escalated radiation for human papillomavirus virus-related oropharyngeal
cancer: Who, why, what, where, when, how, how much...and what next?
Radiother Oncol. 2024;200:110373. PubMedAbstract available
CHEN B, Zhan Z, Xu Y, Yu S, et al Long-term trends in the burden of nasopharyngeal carcinoma in China: A
comprehensive analysis from 1990 to 2021 and projections to 2030 based on the
global burden of disease study 2021.
Radiother Oncol. 2024 Nov 1:110613. doi: 10.1016/j.radonc.2024.110613. PubMedAbstract available
October 2024
TATTENBERG S, Shin J, Hoehr C, Sung W, et al Correlation of dynamic blood dose with clinical outcomes in radiotherapy for
head-and-neck cancer.
Radiother Oncol. 2024 Oct 29:110603. doi: 10.1016/j.radonc.2024.110603. PubMedAbstract available
GAITO S, Hwang E, Thwaites D, Ahern V, et al Identifying paediatric patients at risk of severe hearing impairment after
treatment for malignancies of the H&N/CNS with proton therapy.
Radiother Oncol. 2024 Oct 26:110597. doi: 10.1016/j.radonc.2024.110597. PubMedAbstract available
FELDMAN J, Pryanichnikov A, Shwartz D, Hillman Y, et al Study of upright patient positioning reproducibility in image-guided proton
therapy for head and neck cancers.
Radiother Oncol. 2024;201:110572. PubMedAbstract available
LIANG Z, Luo C, Li S, Zhu Y, et al Guiding induction chemotherapy of locoregionally advanced nasopharyngeal
carcinoma with ternary classification of predicted individual treatment effect.
Radiother Oncol. 2024 Oct 9:110571. doi: 10.1016/j.radonc.2024.110571. PubMedAbstract available
PAN J, Qiu Z, Fu G, Liang J, et al Non-complete recovery of temporal lobe white matter diffusion metrics at one year
Post-Radiotherapy: Implications for Radiation-Induced necrosis risk.
Radiother Oncol. 2024;199:110420. PubMedAbstract available
September 2024
THIRUVENGADAM R, Kim SH, Thiruvengadam M Fructose 1,6-bisphosphate aldolase: A promising prognostic marker for oral cancer
and its role in radiotherapy response.
Radiother Oncol. 2024;200:110537. PubMedAbstract available
DAVE J Concerns regarding the use of only phase 2 study to Justify palliative
radiotherapy vs. Palliative chemo-radiotherapy in unresectable head and neck
cancer.
Radiother Oncol. 2024;200:110526. PubMed
KONG W, Huiskes M, Habraken SJM, Astreinidou E, et al Reducing the lateral dose penumbra in IMPT by incorporating transmission pencil
beams.
Radiother Oncol. 2024;198:110388. PubMedAbstract available
August 2024
YANG Y, Shao R, Cao X, Chen M, et al Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable
esophageal squamous cell carcinoma: A pooled analysis of randomized clinical
trials.
Radiother Oncol. 2024;200:110517. PubMedAbstract available
ZHU WY, Huang J, Lu ZQ, Yang S, et al Management of post-radiation carotid blowout syndrome in patients with head and
neck cancer: A systematic review.
Radiother Oncol. 2024;200:110502. PubMedAbstract available
CHEN L, Wang H, Chen W, Li K, et al Induction plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy
in elderly patients with locoregionally advanced nasopharyngeal carcinoma.
Radiother Oncol. 2024 Aug 25:110497. doi: 10.1016/j.radonc.2024.110497. PubMedAbstract available
REINEMA FV, Hudson N, Adema GJ, Peeters WJM, et al MitoTam induces ferroptosis and increases radiosensitivity in head and neck
cancer cells.
Radiother Oncol. 2024;200:110503. PubMedAbstract available
BEUKEMA JC, Haveman JW, Langendijk JA, Oldehinkel E, et al Blood biomarkers for cardiac damage during and after radiotherapy for esophageal
cancer: A prospective cohort study.
Radiother Oncol. 2024;200:110479. PubMedAbstract available
TOPKAN E, Somay E, Selek U Comment on: Re-irradiation versus systemic therapy for the management of
local-regionally recurrent head and neck cancer.
Radiother Oncol. 2024;199:110467. PubMed
MA B, Guo J, De Biase A, van Dijk LV, et al PET/CT based transformer model for multi-outcome prediction in oropharyngeal
cancer.
Radiother Oncol. 2024;197:110368. PubMedAbstract available
July 2024
SATO M, Hirose K A simple prediction model for the risk of boron neutron capture therapy-induced
nausea and vomiting in head and neck cancer.
Radiother Oncol. 2024;199:110464. PubMedAbstract available
MENESES AG, Ferreira EB, Vieira LAC, Bontempo PSM, et al Comparison of liposomal gel with and without addition of chamomile for prevention
of radiation dermatitis in head and neck cancer patients: A randomized controlled
trial.
Radiother Oncol. 2024;199:110440. PubMedAbstract available
XIE C, Yu X, Tan N, Zhang J, et al Combined deep learning and radiomics in pretreatment radiation esophagitis
prediction for patients with esophageal cancer underwent volumetric modulated arc
therapy.
Radiother Oncol. 2024;199:110438. PubMedAbstract available
ZUKAUSKAITE R, Kristensen MH, Eriksen JG, Johansen J, et al Comparison of 3-year local control using DAHANCA radiotherapy guidelines before
and after implementation of five millimetres geometrical GTV to high-dose CTV
margin.
Radiother Oncol. 2024;196:110284. PubMedAbstract available
CHIANG CL, Chan KSK, Li H, Ng WT, et al Using the genomic adjusted radiation dose (GARD) to personalize the radiation
dose in nasopharyngeal cancer.
Radiother Oncol. 2024;196:110287. PubMedAbstract available
FITZGERALD KT, Lyons C, England A, McEntee MF, et al Response to letter to the editor by Somay et al., re: "Risk factors associated
with the development of osteoradionecrosis (ORN) in head and neck cancer patients
in Ireland: A 10-year retrospective review".
Radiother Oncol. 2024 Jul 1:110412. doi: 10.1016/j.radonc.2024.110412. PubMed
June 2024
NAVRAN A, Kayembe MT, Gouw ZAR, Vogel WV, et al FGD-PET/CT three months after (chemo)radiotherapy for head and neck squamous cell
carcinoma spares considerable number of patients from a salvage neck dissection.
Radiother Oncol. 2024;198:110407. PubMedAbstract available
TOPKAN E, Somay E, Selek U Letter to the editor regarding "Risk factors associated with the development of
osteoradionecrosis (ORN) in head and neck cancer patients in Ireland: A 10-year
retrospective review".
Radiother Oncol. 2024 Jun 25:110411. doi: 10.1016/j.radonc.2024.110411. PubMed
CANTERS R, van der Klugt K, Trier Taasti V, Buijsen J, et al Robustness of intensity modulated proton treatment of esophageal cancer for
anatomical changes and breathing motion.
Radiother Oncol. 2024 Jun 23:110409. doi: 10.1016/j.radonc.2024.110409. PubMedAbstract available
SATO M, Hirose K Efficacy and safety of boron neutron capture therapy for Hypopharyngeal/Laryngeal
cancer patients with previous head and neck irradiation in Japan.
Radiother Oncol. 2024 Jun 14:110382. doi: 10.1016/j.radonc.2024.110382. PubMedAbstract available
MOORE-PALHARES D, Saifuddin M, Dasgupta A, Anzola Pena ML, et al Radiation enhancement using focussed ultrasound-stimulated microbubbles for head
and neck cancer: A phase 1 clinical trial.
Radiother Oncol. 2024;198:110380. PubMedAbstract available
ZHOU H, Zhao Q, Huang W, Liang Z, et al A novel fully automatic segmentation and counting system for metastatic lymph
nodes on multimodal magnetic resonance Imaging: Evaluation and prognostic
implications in Nasopharyngeal carcinoma.
Radiother Oncol. 2024 Jun 2:110367. doi: 10.1016/j.radonc.2024.110367. PubMedAbstract available
LIU YC, Zhang X, Yang HN, Zhang L, et al Proposals for the delineation of neck clinical target volume for definitive
Radiation therapy in patients with oral/ oropharyngeal squamous cell cancer based
on lymph node distribution.
Radiother Oncol. 2024;195:110225. PubMedAbstract available
May 2024
JOSE BESSO M, Bitto V, Koi L, Wijaya Hadiwikarta W, et al Transcriptomic and epigenetic landscape of nimorazole-enhanced radiochemotherapy
in head and neck cancer.
Radiother Oncol. 2024 May 30:110348. doi: 10.1016/j.radonc.2024.110348. PubMedAbstract available
GEHIN W, Chastagner P, Mansuy L, Bernier-Chastagner V, et al Dosimetric analysis of hearing loss after cranial radiation therapy in children:
A single-institution study from the french national registry pediart.
Radiother Oncol. 2024 May 26:110346. doi: 10.1016/j.radonc.2024.110346. PubMedAbstract available
SONG J, Yang X, Wu J, Wu Z, et al The association analysis between fatigue and body composition loss in patients
with nasopharyngeal carcinoma during radiotherapy: An observational longitudinal
study.
Radiother Oncol. 2024 May 24:110340. doi: 10.1016/j.radonc.2024.110340. PubMedAbstract available
ZHANG L, Jin S, Wang Y, Zhang Z, et al Predict nutrition-related adverse outcomes in head and neck cancer patients
undergoing radiotherapy: A systematic review.
Radiother Oncol. 2024 May 23:110339. doi: 10.1016/j.radonc.2024.110339. PubMedAbstract available
NIELSEN CP, Lorenzen EL, Jensen K, Eriksen JG, et al Interobserver variation in organs at risk contouring in head and neck cancer
according to the DAHANCA guidelines.
Radiother Oncol. 2024;197:110337. PubMed
BOREL C, Sun XS, Coutte A, Bera G, et al Standard versus fractionated high-dose cisplatin plus radiation for locally
advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized
phase II trial.
Radiother Oncol. 2024;197:110329. PubMedAbstract available
ZHANG WW, Guo R Response to "Comments on 'Radiotherapy alone versus concurrent chemoradiotherapy
in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse
features: A propensity score-matched cohort study'".
Radiother Oncol. 2024 May 11:110327. doi: 10.1016/j.radonc.2024.110327. PubMed
ZHAN ZJ, Huang HY, Xiao YH, Zhao YP, et al Anxiety and depression in nasopharyngeal carcinoma patients and network analysis
to identify central symptoms: A cross-sectional study from a high-incidence area.
Radiother Oncol. 2024 May 10:110324. doi: 10.1016/j.radonc.2024.110324. PubMedAbstract available
SHEN M, Lin X, Yang C, Zhou Z, et al Potential predictive value of IVIM MR for xerostomia in nasopharyngeal carcinoma.
Radiother Oncol. 2024 May 9:110323. doi: 10.1016/j.radonc.2024.110323. PubMedAbstract available
SMITS HJG, Raaijmakers CPJ, de Ridder M, Gouw ZAR, et al Improved delineation with diffusion weighted imaging for laryngeal and
hypopharyngeal tumors validated with pathology.
Radiother Oncol. 2024;194:110182. PubMedAbstract available
April 2024
XU L, Liu S, Yang Y, Shu L, et al LINC00313 suppresses autophagy and promotes stemness of nasopharyngeal carcinoma
cells through PTBP1/STIM1 axis.
Radiother Oncol. 2024;196:110310. PubMedAbstract available
LIU Y, Ma J, Zeng XY, Zuo ZC, et al Efficacy of metastatic lesion radiotherapy in patients with metastatic
nasopharyngeal carcinoma: A multicenter retrospective study.
Radiother Oncol. 2024;196:110311. PubMedAbstract available
STARUCH M, Speth MM, Neyer P, Riesterer O, et al Radiation-associated changes in saliva composition of head and neck cancer
patients: A systematic review.
Radiother Oncol. 2024 Apr 20:110279. doi: 10.1016/j.radonc.2024.110279. PubMedAbstract available
SELENGE BEDUK ESEN C, Nur Can G, Akkus Yildirim B Comments on "Radiotherapy alone versus concurrent chemoradiotherapy in patients
with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A
propensity score-matched cohort study".
Radiother Oncol. 2024 Apr 20:110292. doi: 10.1016/j.radonc.2024.110292. PubMed
FITZGERALD KT, Lyons C, England A, McEntee MF, et al Risk factors associated with the development of osteoradionecrosis (ORN) in Head
and Neck cancer patients in Ireland: A 10-year retrospective review.
Radiother Oncol. 2024 Apr 17:110286. doi: 10.1016/j.radonc.2024.110286. PubMedAbstract available
ZHENG Z, Shen Y, Su J, Ji X, et al Assessing radiation-induced carotid artery injury using ultrasound in patients
with head and neck cancer.
Radiother Oncol. 2024 Apr 17:110285. doi: 10.1016/j.radonc.2024.110285. PubMedAbstract available
CHEN AM, Harris JP, Nabar R, Tjoa T, et al Re-irradiation versus systemic therapy for the management of local-regionally
recurrent head and neck cancer.
Radiother Oncol. 2024 Apr 16:110278. doi: 10.1016/j.radonc.2024.110278. PubMedAbstract available
DE LEEUW ALMP, Giralt J, Tao Y, Benavente S, et al A multicentric randomized controlled phase III trial of adaptive and
18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous
cell carcinoma (ARTFORCE).
Radiother Oncol. 2024 Apr 16:110281. doi: 10.1016/j.radonc.2024.110281. PubMedAbstract available
SHUANG H, Feng J, Caineng C, Qifeng J, et al Long-term efficacy analysis of radiotherapy and local management of metastases in
patients with newly diagnosed oligometastatic nasopharyngeal carcinoma: A
prospective, single-arm, single-center clinical study.
Radiother Oncol. 2024 Apr 5:110265. doi: 10.1016/j.radonc.2024.110265. PubMedAbstract available
CHOW JCH, Lee J, Lai MMP, Li S, et al Multi-domain neurocognitive impairment following definitive intensity-modulated
radiotherapy for nasopharyngeal cancer: A cross-sectional study.
Radiother Oncol. 2024;193:110143. PubMedAbstract available
March 2024
DONG J, Ng WT, Wong CHL, Li JS, et al Dosimetric parameters predict radiation-induced temporal lobe necrosis in
nasopharyngeal carcinoma patients: A systematic review and meta-analysis.
Radiother Oncol. 2024 Mar 25:110258. doi: 10.1016/j.radonc.2024.110258. PubMedAbstract available
HUYNH TM, Falk RS, Hellebust TP, Dale E, et al Chronic fatigue in long-term survivors of head and neck cancer treated with
radiotherapy.
Radiother Oncol. 2024;195:110231. PubMedAbstract available
BERTHOLET J, Mackeprang PH, Loebner HA, Mueller S, et al Organs-at-risk dose and normal tissue complication probability with dynamic
trajectory radiotherapy (DTRT) for head and neck cancer.
Radiother Oncol. 2024 Mar 19:110237. doi: 10.1016/j.radonc.2024.110237. PubMedAbstract available
BOON CS, Ramkumar S, Boon IS Proton beam radiotherapy head and neck cancer study design and endpoints.
Radiother Oncol. 2024 Mar 16:110234. doi: 10.1016/j.radonc.2024.110234. PubMed
KOUTROUMPAKIS E, Mohamed ASR, Chaftari P, Rosenthal DI, et al Longitudinal changes in the carotid arteries of head and neck cancer patients
following radiation therapy: Results from a prospective serial imaging biomarker
characterization study.
Radiother Oncol. 2024 Mar 9:110220. doi: 10.1016/j.radonc.2024.110220. PubMedAbstract available
CHOW JCH, Ho JCS, Man Cheung K, Johnson D, et al Neurological complications of modern radiotherapy for head and neck cancer.
Radiother Oncol. 2024 Mar 2:110200. doi: 10.1016/j.radonc.2024.110200. PubMedAbstract available
CARSUZAA F, Chary E, Thariat J, Dufour X, et al Obstructive sleep apnea syndrome: A frequent and difficult-to-detect complication
of radiotherapy for oropharyngeal cancers.
Radiother Oncol. 2024;192:110109. PubMedAbstract available
ZHANG WW, Lin JY, Wang GY, Huang CL, et al Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II
and T3N0 nasopharyngeal carcinoma with adverse features: A propensity
score-matched cohort study.
Radiother Oncol. 2024;194:110189. PubMedAbstract available
February 2024
POPULAIRE P, Defraene G, Haustermans K Letter to the editor regarding "External validation of a lung cancer-based
prediction model for two-year mortality in esophageal cancer patient cohorts" by
M. Berbee et al.
Radiother Oncol. 2024 Feb 28:110175. doi: 10.1016/j.radonc.2024.110175. PubMed
KOTO M, Ikawa H, Inaniwa T, Imai R, et al Dose-averaged LET optimized carbon-ion radiotherapy for head and neck cancers.
Radiother Oncol. 2024;194:110180. PubMedAbstract available
November 2023
VERDUIJN GM, Sijtsema ND, van Norden Y, Heemsbergen WD, et al Accounting for fractionation and heterogeneous dose distributions in the
modelling of osteoradionecrosis in oropharyngeal carcinoma treatment.
Radiother Oncol. 2023;188:109889. PubMedAbstract available
October 2023
CHANG CL, Lin KC, Chen WM, Shia BC, et al Comparing the Oncologic Outcomes of Proton Therapy and Intensity-Modulated
Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
Radiother Oncol. 2023 Oct 28:109971. doi: 10.1016/j.radonc.2023.109971. PubMedAbstract available